Benign Prostatic Hyperplasic Device Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Benign Prostatic Hyperplasic Device in global, including the following market information:
Global Benign Prostatic Hyperplasic Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Benign Prostatic Hyperplasic Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Benign Prostatic Hyperplasic Device companies in 2021 (%)
The global Benign Prostatic Hyperplasic Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiofrequency Ablation Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Benign Prostatic Hyperplasic Device include KARL STORZ SE, Richard Wolf GmbH, Olympus Corporation, Urologix, Boston Scientific Corporation, Butterfly, TELEFLEX Incorporated, OmniGuide Holdings and Convergent Laser Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Benign Prostatic Hyperplasic Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Benign Prostatic Hyperplasic Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Benign Prostatic Hyperplasic Device Market Segment Percentages, by Type, 2021 (%)
Global Benign Prostatic Hyperplasic Device Market Segment Percentages, by Application, 2021 (%)
Global Benign Prostatic Hyperplasic Device Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Benign Prostatic Hyperplasic Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Benign Prostatic Hyperplasic Device revenues share in global market, 2021 (%)
Key companies Benign Prostatic Hyperplasic Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Benign Prostatic Hyperplasic Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Benign Prostatic Hyperplasic Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Benign Prostatic Hyperplasic Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Benign Prostatic Hyperplasic Device companies in 2021 (%)
The global Benign Prostatic Hyperplasic Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiofrequency Ablation Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Benign Prostatic Hyperplasic Device include KARL STORZ SE, Richard Wolf GmbH, Olympus Corporation, Urologix, Boston Scientific Corporation, Butterfly, TELEFLEX Incorporated, OmniGuide Holdings and Convergent Laser Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Benign Prostatic Hyperplasic Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Benign Prostatic Hyperplasic Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Benign Prostatic Hyperplasic Device Market Segment Percentages, by Type, 2021 (%)
- Radiofrequency Ablation Devices
- Urology Lasers Devices
- Others
Global Benign Prostatic Hyperplasic Device Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Others
Global Benign Prostatic Hyperplasic Device Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Benign Prostatic Hyperplasic Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Benign Prostatic Hyperplasic Device revenues share in global market, 2021 (%)
Key companies Benign Prostatic Hyperplasic Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Benign Prostatic Hyperplasic Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- KARL STORZ SE
- Richard Wolf GmbH
- Olympus Corporation
- Urologix
- Boston Scientific Corporation
- Butterfly
- TELEFLEX Incorporated
- OmniGuide Holdings
- Convergent Laser Technologies
- ProArc
- Olympus Corporation
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Benign Prostatic Hyperplasic Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Benign Prostatic Hyperplasic Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BENIGN PROSTATIC HYPERPLASIC DEVICE OVERALL MARKET SIZE
2.1 Global Benign Prostatic Hyperplasic Device Market Size: 2021 VS 2028
2.2 Global Benign Prostatic Hyperplasic Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Benign Prostatic Hyperplasic Device Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Benign Prostatic Hyperplasic Device Players in Global Market
3.2 Top Global Benign Prostatic Hyperplasic Device Companies Ranked by Revenue
3.3 Global Benign Prostatic Hyperplasic Device Revenue by Companies
3.4 Global Benign Prostatic Hyperplasic Device Sales by Companies
3.5 Global Benign Prostatic Hyperplasic Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Benign Prostatic Hyperplasic Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Benign Prostatic Hyperplasic Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Benign Prostatic Hyperplasic Device Players in Global Market
3.8.1 List of Global Tier 1 Benign Prostatic Hyperplasic Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasic Device Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Benign Prostatic Hyperplasic Device Market Size Markets, 2021 & 2028
4.1.2 Radiofrequency Ablation Devices
4.1.3 Urology Lasers Devices
4.1.4 Others
4.2 By Type - Global Benign Prostatic Hyperplasic Device Revenue & Forecasts
4.2.1 By Type - Global Benign Prostatic Hyperplasic Device Revenue, 2017-2022
4.2.2 By Type - Global Benign Prostatic Hyperplasic Device Revenue, 2023-2028
4.2.3 By Type - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
4.3 By Type - Global Benign Prostatic Hyperplasic Device Sales & Forecasts
4.3.1 By Type - Global Benign Prostatic Hyperplasic Device Sales, 2017-2022
4.3.2 By Type - Global Benign Prostatic Hyperplasic Device Sales, 2023-2028
4.3.3 By Type - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
4.4 By Type - Global Benign Prostatic Hyperplasic Device Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Benign Prostatic Hyperplasic Device Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Benign Prostatic Hyperplasic Device Revenue & Forecasts
5.2.1 By Application - Global Benign Prostatic Hyperplasic Device Revenue, 2017-2022
5.2.2 By Application - Global Benign Prostatic Hyperplasic Device Revenue, 2023-2028
5.2.3 By Application - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
5.3 By Application - Global Benign Prostatic Hyperplasic Device Sales & Forecasts
5.3.1 By Application - Global Benign Prostatic Hyperplasic Device Sales, 2017-2022
5.3.2 By Application - Global Benign Prostatic Hyperplasic Device Sales, 2023-2028
5.3.3 By Application - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
5.4 By Application - Global Benign Prostatic Hyperplasic Device Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Benign Prostatic Hyperplasic Device Market Size, 2021 & 2028
6.2 By Region - Global Benign Prostatic Hyperplasic Device Revenue & Forecasts
6.2.1 By Region - Global Benign Prostatic Hyperplasic Device Revenue, 2017-2022
6.2.2 By Region - Global Benign Prostatic Hyperplasic Device Revenue, 2023-2028
6.2.3 By Region - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
6.3 By Region - Global Benign Prostatic Hyperplasic Device Sales & Forecasts
6.3.1 By Region - Global Benign Prostatic Hyperplasic Device Sales, 2017-2022
6.3.2 By Region - Global Benign Prostatic Hyperplasic Device Sales, 2023-2028
6.3.3 By Region - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.4.2 By Country - North America Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.4.3 US Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.4.4 Canada Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.4.5 Mexico Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.5.2 By Country - Europe Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.5.3 Germany Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.4 France Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.5 U.K. Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.6 Italy Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.7 Russia Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.8 Nordic Countries Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.9 Benelux Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.6.2 By Region - Asia Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.6.3 China Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6.4 Japan Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6.5 South Korea Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6.6 Southeast Asia Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6.7 India Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.7.2 By Country - South America Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.7.3 Brazil Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.7.4 Argentina Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.8.3 Turkey Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.8.4 Israel Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.8.5 Saudi Arabia Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.8.6 UAE Benign Prostatic Hyperplasic Device Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 KARL STORZ SE
7.1.1 KARL STORZ SE Corporate Summary
7.1.2 KARL STORZ SE Business Overview
7.1.3 KARL STORZ SE Benign Prostatic Hyperplasic Device Major Product Offerings
7.1.4 KARL STORZ SE Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.1.5 KARL STORZ SE Key News
7.2 Richard Wolf GmbH
7.2.1 Richard Wolf GmbH Corporate Summary
7.2.2 Richard Wolf GmbH Business Overview
7.2.3 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Major Product Offerings
7.2.4 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.2.5 Richard Wolf GmbH Key News
7.3 Olympus Corporation
7.3.1 Olympus Corporation Corporate Summary
7.3.2 Olympus Corporation Business Overview
7.3.3 Olympus Corporation Benign Prostatic Hyperplasic Device Major Product Offerings
7.3.4 Olympus Corporation Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.3.5 Olympus Corporation Key News
7.4 Urologix
7.4.1 Urologix Corporate Summary
7.4.2 Urologix Business Overview
7.4.3 Urologix Benign Prostatic Hyperplasic Device Major Product Offerings
7.4.4 Urologix Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.4.5 Urologix Key News
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Corporate Summary
7.5.2 Boston Scientific Corporation Business Overview
7.5.3 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Major Product Offerings
7.5.4 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.5.5 Boston Scientific Corporation Key News
7.6 Butterfly
7.6.1 Butterfly Corporate Summary
7.6.2 Butterfly Business Overview
7.6.3 Butterfly Benign Prostatic Hyperplasic Device Major Product Offerings
7.6.4 Butterfly Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.6.5 Butterfly Key News
7.7 TELEFLEX Incorporated
7.7.1 TELEFLEX Incorporated Corporate Summary
7.7.2 TELEFLEX Incorporated Business Overview
7.7.3 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Major Product Offerings
7.7.4 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.7.5 TELEFLEX Incorporated Key News
7.8 OmniGuide Holdings
7.8.1 OmniGuide Holdings Corporate Summary
7.8.2 OmniGuide Holdings Business Overview
7.8.3 OmniGuide Holdings Benign Prostatic Hyperplasic Device Major Product Offerings
7.8.4 OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.8.5 OmniGuide Holdings Key News
7.9 Convergent Laser Technologies
7.9.1 Convergent Laser Technologies Corporate Summary
7.9.2 Convergent Laser Technologies Business Overview
7.9.3 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Major Product Offerings
7.9.4 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.9.5 Convergent Laser Technologies Key News
7.10 ProArc
7.10.1 ProArc Corporate Summary
7.10.2 ProArc Business Overview
7.10.3 ProArc Benign Prostatic Hyperplasic Device Major Product Offerings
7.10.4 ProArc Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.10.5 ProArc Key News
7.11 Olympus Corporation
7.11.1 Olympus Corporation Corporate Summary
7.11.2 Olympus Corporation Benign Prostatic Hyperplasic Device Business Overview
7.11.3 Olympus Corporation Benign Prostatic Hyperplasic Device Major Product Offerings
7.11.4 Olympus Corporation Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.11.5 Olympus Corporation Key News
8 GLOBAL BENIGN PROSTATIC HYPERPLASIC DEVICE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Benign Prostatic Hyperplasic Device Production Capacity, 2017-2028
8.2 Benign Prostatic Hyperplasic Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Benign Prostatic Hyperplasic Device Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BENIGN PROSTATIC HYPERPLASIC DEVICE SUPPLY CHAIN ANALYSIS
10.1 Benign Prostatic Hyperplasic Device Industry Value Chain
10.2 Benign Prostatic Hyperplasic Device Upstream Market
10.3 Benign Prostatic Hyperplasic Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Benign Prostatic Hyperplasic Device Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Benign Prostatic Hyperplasic Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Benign Prostatic Hyperplasic Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BENIGN PROSTATIC HYPERPLASIC DEVICE OVERALL MARKET SIZE
2.1 Global Benign Prostatic Hyperplasic Device Market Size: 2021 VS 2028
2.2 Global Benign Prostatic Hyperplasic Device Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Benign Prostatic Hyperplasic Device Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Benign Prostatic Hyperplasic Device Players in Global Market
3.2 Top Global Benign Prostatic Hyperplasic Device Companies Ranked by Revenue
3.3 Global Benign Prostatic Hyperplasic Device Revenue by Companies
3.4 Global Benign Prostatic Hyperplasic Device Sales by Companies
3.5 Global Benign Prostatic Hyperplasic Device Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Benign Prostatic Hyperplasic Device Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Benign Prostatic Hyperplasic Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Benign Prostatic Hyperplasic Device Players in Global Market
3.8.1 List of Global Tier 1 Benign Prostatic Hyperplasic Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasic Device Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Benign Prostatic Hyperplasic Device Market Size Markets, 2021 & 2028
4.1.2 Radiofrequency Ablation Devices
4.1.3 Urology Lasers Devices
4.1.4 Others
4.2 By Type - Global Benign Prostatic Hyperplasic Device Revenue & Forecasts
4.2.1 By Type - Global Benign Prostatic Hyperplasic Device Revenue, 2017-2022
4.2.2 By Type - Global Benign Prostatic Hyperplasic Device Revenue, 2023-2028
4.2.3 By Type - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
4.3 By Type - Global Benign Prostatic Hyperplasic Device Sales & Forecasts
4.3.1 By Type - Global Benign Prostatic Hyperplasic Device Sales, 2017-2022
4.3.2 By Type - Global Benign Prostatic Hyperplasic Device Sales, 2023-2028
4.3.3 By Type - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
4.4 By Type - Global Benign Prostatic Hyperplasic Device Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Benign Prostatic Hyperplasic Device Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Benign Prostatic Hyperplasic Device Revenue & Forecasts
5.2.1 By Application - Global Benign Prostatic Hyperplasic Device Revenue, 2017-2022
5.2.2 By Application - Global Benign Prostatic Hyperplasic Device Revenue, 2023-2028
5.2.3 By Application - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
5.3 By Application - Global Benign Prostatic Hyperplasic Device Sales & Forecasts
5.3.1 By Application - Global Benign Prostatic Hyperplasic Device Sales, 2017-2022
5.3.2 By Application - Global Benign Prostatic Hyperplasic Device Sales, 2023-2028
5.3.3 By Application - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
5.4 By Application - Global Benign Prostatic Hyperplasic Device Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Benign Prostatic Hyperplasic Device Market Size, 2021 & 2028
6.2 By Region - Global Benign Prostatic Hyperplasic Device Revenue & Forecasts
6.2.1 By Region - Global Benign Prostatic Hyperplasic Device Revenue, 2017-2022
6.2.2 By Region - Global Benign Prostatic Hyperplasic Device Revenue, 2023-2028
6.2.3 By Region - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
6.3 By Region - Global Benign Prostatic Hyperplasic Device Sales & Forecasts
6.3.1 By Region - Global Benign Prostatic Hyperplasic Device Sales, 2017-2022
6.3.2 By Region - Global Benign Prostatic Hyperplasic Device Sales, 2023-2028
6.3.3 By Region - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.4.2 By Country - North America Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.4.3 US Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.4.4 Canada Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.4.5 Mexico Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.5.2 By Country - Europe Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.5.3 Germany Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.4 France Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.5 U.K. Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.6 Italy Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.7 Russia Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.8 Nordic Countries Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.5.9 Benelux Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.6.2 By Region - Asia Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.6.3 China Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6.4 Japan Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6.5 South Korea Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6.6 Southeast Asia Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.6.7 India Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.7.2 By Country - South America Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.7.3 Brazil Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.7.4 Argentina Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Sales, 2017-2028
6.8.3 Turkey Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.8.4 Israel Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.8.5 Saudi Arabia Benign Prostatic Hyperplasic Device Market Size, 2017-2028
6.8.6 UAE Benign Prostatic Hyperplasic Device Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 KARL STORZ SE
7.1.1 KARL STORZ SE Corporate Summary
7.1.2 KARL STORZ SE Business Overview
7.1.3 KARL STORZ SE Benign Prostatic Hyperplasic Device Major Product Offerings
7.1.4 KARL STORZ SE Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.1.5 KARL STORZ SE Key News
7.2 Richard Wolf GmbH
7.2.1 Richard Wolf GmbH Corporate Summary
7.2.2 Richard Wolf GmbH Business Overview
7.2.3 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Major Product Offerings
7.2.4 Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.2.5 Richard Wolf GmbH Key News
7.3 Olympus Corporation
7.3.1 Olympus Corporation Corporate Summary
7.3.2 Olympus Corporation Business Overview
7.3.3 Olympus Corporation Benign Prostatic Hyperplasic Device Major Product Offerings
7.3.4 Olympus Corporation Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.3.5 Olympus Corporation Key News
7.4 Urologix
7.4.1 Urologix Corporate Summary
7.4.2 Urologix Business Overview
7.4.3 Urologix Benign Prostatic Hyperplasic Device Major Product Offerings
7.4.4 Urologix Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.4.5 Urologix Key News
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Corporate Summary
7.5.2 Boston Scientific Corporation Business Overview
7.5.3 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Major Product Offerings
7.5.4 Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.5.5 Boston Scientific Corporation Key News
7.6 Butterfly
7.6.1 Butterfly Corporate Summary
7.6.2 Butterfly Business Overview
7.6.3 Butterfly Benign Prostatic Hyperplasic Device Major Product Offerings
7.6.4 Butterfly Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.6.5 Butterfly Key News
7.7 TELEFLEX Incorporated
7.7.1 TELEFLEX Incorporated Corporate Summary
7.7.2 TELEFLEX Incorporated Business Overview
7.7.3 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Major Product Offerings
7.7.4 TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.7.5 TELEFLEX Incorporated Key News
7.8 OmniGuide Holdings
7.8.1 OmniGuide Holdings Corporate Summary
7.8.2 OmniGuide Holdings Business Overview
7.8.3 OmniGuide Holdings Benign Prostatic Hyperplasic Device Major Product Offerings
7.8.4 OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.8.5 OmniGuide Holdings Key News
7.9 Convergent Laser Technologies
7.9.1 Convergent Laser Technologies Corporate Summary
7.9.2 Convergent Laser Technologies Business Overview
7.9.3 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Major Product Offerings
7.9.4 Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.9.5 Convergent Laser Technologies Key News
7.10 ProArc
7.10.1 ProArc Corporate Summary
7.10.2 ProArc Business Overview
7.10.3 ProArc Benign Prostatic Hyperplasic Device Major Product Offerings
7.10.4 ProArc Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.10.5 ProArc Key News
7.11 Olympus Corporation
7.11.1 Olympus Corporation Corporate Summary
7.11.2 Olympus Corporation Benign Prostatic Hyperplasic Device Business Overview
7.11.3 Olympus Corporation Benign Prostatic Hyperplasic Device Major Product Offerings
7.11.4 Olympus Corporation Benign Prostatic Hyperplasic Device Sales and Revenue in Global (2017-2022)
7.11.5 Olympus Corporation Key News
8 GLOBAL BENIGN PROSTATIC HYPERPLASIC DEVICE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Benign Prostatic Hyperplasic Device Production Capacity, 2017-2028
8.2 Benign Prostatic Hyperplasic Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Benign Prostatic Hyperplasic Device Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BENIGN PROSTATIC HYPERPLASIC DEVICE SUPPLY CHAIN ANALYSIS
10.1 Benign Prostatic Hyperplasic Device Industry Value Chain
10.2 Benign Prostatic Hyperplasic Device Upstream Market
10.3 Benign Prostatic Hyperplasic Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Benign Prostatic Hyperplasic Device Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Benign Prostatic Hyperplasic Device in Global Market
Table 2. Top Benign Prostatic Hyperplasic Device Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Benign Prostatic Hyperplasic Device Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Benign Prostatic Hyperplasic Device Revenue Share by Companies, 2017-2022
Table 5. Global Benign Prostatic Hyperplasic Device Sales by Companies, (K Units), 2017-2022
Table 6. Global Benign Prostatic Hyperplasic Device Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Benign Prostatic Hyperplasic Device Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Benign Prostatic Hyperplasic Device Product Type
Table 9. List of Global Tier 1 Benign Prostatic Hyperplasic Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasic Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2017-2022
Table 15. By Type - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2023-2028
Table 16. By Application – Global Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2017-2022
Table 20. By Application - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2023-2028
Table 21. By Region – Global Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2017-2022
Table 25. By Region - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2023-2028
Table 26. By Country - North America Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 29. By Country - North America Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 30. By Country - Europe Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 33. By Country - Europe Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 34. By Region - Asia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 37. By Region - Asia Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 38. By Country - South America Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 41. By Country - South America Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 46. KARL STORZ SE Corporate Summary
Table 47. KARL STORZ SE Benign Prostatic Hyperplasic Device Product Offerings
Table 48. KARL STORZ SE Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Richard Wolf GmbH Corporate Summary
Table 50. Richard Wolf GmbH Benign Prostatic Hyperplasic Device Product Offerings
Table 51. Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Olympus Corporation Corporate Summary
Table 53. Olympus Corporation Benign Prostatic Hyperplasic Device Product Offerings
Table 54. Olympus Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Urologix Corporate Summary
Table 56. Urologix Benign Prostatic Hyperplasic Device Product Offerings
Table 57. Urologix Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Boston Scientific Corporation Corporate Summary
Table 59. Boston Scientific Corporation Benign Prostatic Hyperplasic Device Product Offerings
Table 60. Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Butterfly Corporate Summary
Table 62. Butterfly Benign Prostatic Hyperplasic Device Product Offerings
Table 63. Butterfly Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. TELEFLEX Incorporated Corporate Summary
Table 65. TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Product Offerings
Table 66. TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. OmniGuide Holdings Corporate Summary
Table 68. OmniGuide Holdings Benign Prostatic Hyperplasic Device Product Offerings
Table 69. OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Convergent Laser Technologies Corporate Summary
Table 71. Convergent Laser Technologies Benign Prostatic Hyperplasic Device Product Offerings
Table 72. Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. ProArc Corporate Summary
Table 74. ProArc Benign Prostatic Hyperplasic Device Product Offerings
Table 75. ProArc Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Olympus Corporation Corporate Summary
Table 77. Olympus Corporation Benign Prostatic Hyperplasic Device Product Offerings
Table 78. Olympus Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Benign Prostatic Hyperplasic Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Benign Prostatic Hyperplasic Device Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Benign Prostatic Hyperplasic Device Production by Region, 2017-2022 (K Units)
Table 82. Global Benign Prostatic Hyperplasic Device Production by Region, 2023-2028 (K Units)
Table 83. Benign Prostatic Hyperplasic Device Market Opportunities & Trends in Global Market
Table 84. Benign Prostatic Hyperplasic Device Market Drivers in Global Market
Table 85. Benign Prostatic Hyperplasic Device Market Restraints in Global Market
Table 86. Benign Prostatic Hyperplasic Device Raw Materials
Table 87. Benign Prostatic Hyperplasic Device Raw Materials Suppliers in Global Market
Table 88. Typical Benign Prostatic Hyperplasic Device Downstream
Table 89. Benign Prostatic Hyperplasic Device Downstream Clients in Global Market
Table 90. Benign Prostatic Hyperplasic Device Distributors and Sales Agents in Global Market
Table 1. Key Players of Benign Prostatic Hyperplasic Device in Global Market
Table 2. Top Benign Prostatic Hyperplasic Device Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Benign Prostatic Hyperplasic Device Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Benign Prostatic Hyperplasic Device Revenue Share by Companies, 2017-2022
Table 5. Global Benign Prostatic Hyperplasic Device Sales by Companies, (K Units), 2017-2022
Table 6. Global Benign Prostatic Hyperplasic Device Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Benign Prostatic Hyperplasic Device Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Benign Prostatic Hyperplasic Device Product Type
Table 9. List of Global Tier 1 Benign Prostatic Hyperplasic Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasic Device Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2017-2022
Table 15. By Type - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2023-2028
Table 16. By Application – Global Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2017-2022
Table 20. By Application - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2023-2028
Table 21. By Region – Global Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Benign Prostatic Hyperplasic Device Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2017-2022
Table 25. By Region - Global Benign Prostatic Hyperplasic Device Sales (K Units), 2023-2028
Table 26. By Country - North America Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 29. By Country - North America Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 30. By Country - Europe Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 33. By Country - Europe Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 34. By Region - Asia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 37. By Region - Asia Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 38. By Country - South America Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 41. By Country - South America Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Sales, (K Units), 2023-2028
Table 46. KARL STORZ SE Corporate Summary
Table 47. KARL STORZ SE Benign Prostatic Hyperplasic Device Product Offerings
Table 48. KARL STORZ SE Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Richard Wolf GmbH Corporate Summary
Table 50. Richard Wolf GmbH Benign Prostatic Hyperplasic Device Product Offerings
Table 51. Richard Wolf GmbH Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Olympus Corporation Corporate Summary
Table 53. Olympus Corporation Benign Prostatic Hyperplasic Device Product Offerings
Table 54. Olympus Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Urologix Corporate Summary
Table 56. Urologix Benign Prostatic Hyperplasic Device Product Offerings
Table 57. Urologix Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Boston Scientific Corporation Corporate Summary
Table 59. Boston Scientific Corporation Benign Prostatic Hyperplasic Device Product Offerings
Table 60. Boston Scientific Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Butterfly Corporate Summary
Table 62. Butterfly Benign Prostatic Hyperplasic Device Product Offerings
Table 63. Butterfly Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. TELEFLEX Incorporated Corporate Summary
Table 65. TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Product Offerings
Table 66. TELEFLEX Incorporated Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. OmniGuide Holdings Corporate Summary
Table 68. OmniGuide Holdings Benign Prostatic Hyperplasic Device Product Offerings
Table 69. OmniGuide Holdings Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Convergent Laser Technologies Corporate Summary
Table 71. Convergent Laser Technologies Benign Prostatic Hyperplasic Device Product Offerings
Table 72. Convergent Laser Technologies Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. ProArc Corporate Summary
Table 74. ProArc Benign Prostatic Hyperplasic Device Product Offerings
Table 75. ProArc Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Olympus Corporation Corporate Summary
Table 77. Olympus Corporation Benign Prostatic Hyperplasic Device Product Offerings
Table 78. Olympus Corporation Benign Prostatic Hyperplasic Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Benign Prostatic Hyperplasic Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 80. Global Benign Prostatic Hyperplasic Device Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Benign Prostatic Hyperplasic Device Production by Region, 2017-2022 (K Units)
Table 82. Global Benign Prostatic Hyperplasic Device Production by Region, 2023-2028 (K Units)
Table 83. Benign Prostatic Hyperplasic Device Market Opportunities & Trends in Global Market
Table 84. Benign Prostatic Hyperplasic Device Market Drivers in Global Market
Table 85. Benign Prostatic Hyperplasic Device Market Restraints in Global Market
Table 86. Benign Prostatic Hyperplasic Device Raw Materials
Table 87. Benign Prostatic Hyperplasic Device Raw Materials Suppliers in Global Market
Table 88. Typical Benign Prostatic Hyperplasic Device Downstream
Table 89. Benign Prostatic Hyperplasic Device Downstream Clients in Global Market
Table 90. Benign Prostatic Hyperplasic Device Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Benign Prostatic Hyperplasic Device Segment by Type
Figure 2. Benign Prostatic Hyperplasic Device Segment by Application
Figure 3. Global Benign Prostatic Hyperplasic Device Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Benign Prostatic Hyperplasic Device Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Benign Prostatic Hyperplasic Device Revenue, 2017-2028 (US$, Mn)
Figure 7. Benign Prostatic Hyperplasic Device Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Benign Prostatic Hyperplasic Device Revenue in 2021
Figure 9. By Type - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 10. By Type - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 11. By Type - Global Benign Prostatic Hyperplasic Device Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 13. By Application - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 14. By Application - Global Benign Prostatic Hyperplasic Device Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 16. By Region - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 17. By Country - North America Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 18. By Country - North America Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 19. US Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 24. Germany Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 25. France Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 33. China Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 37. India Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 39. By Country - South America Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 40. Brazil Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 44. Turkey Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 48. Global Benign Prostatic Hyperplasic Device Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Benign Prostatic Hyperplasic Device by Region, 2021 VS 2028
Figure 50. Benign Prostatic Hyperplasic Device Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Benign Prostatic Hyperplasic Device Segment by Type
Figure 2. Benign Prostatic Hyperplasic Device Segment by Application
Figure 3. Global Benign Prostatic Hyperplasic Device Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Benign Prostatic Hyperplasic Device Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Benign Prostatic Hyperplasic Device Revenue, 2017-2028 (US$, Mn)
Figure 7. Benign Prostatic Hyperplasic Device Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Benign Prostatic Hyperplasic Device Revenue in 2021
Figure 9. By Type - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 10. By Type - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 11. By Type - Global Benign Prostatic Hyperplasic Device Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 13. By Application - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 14. By Application - Global Benign Prostatic Hyperplasic Device Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 16. By Region - Global Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 17. By Country - North America Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 18. By Country - North America Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 19. US Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 24. Germany Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 25. France Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 33. China Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 37. India Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 39. By Country - South America Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 40. Brazil Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Benign Prostatic Hyperplasic Device Sales Market Share, 2017-2028
Figure 44. Turkey Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Benign Prostatic Hyperplasic Device Revenue, (US$, Mn), 2017-2028
Figure 48. Global Benign Prostatic Hyperplasic Device Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Benign Prostatic Hyperplasic Device by Region, 2021 VS 2028
Figure 50. Benign Prostatic Hyperplasic Device Industry Value Chain
Figure 51. Marketing Channels
